Tamoxifen-inducible cre-mediated calreticulin excision to study mouse embryonic stem cell differentiation

Stem Cells and Development

Volumn 18, Issue 1, 2009, Pages 187-194

  Szabo, Eva ^a   Soboloff, Jonathan ^a,b   Dziak, Ewa ^a   Opas, Michal ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALRETICULIN; CHAPERONE; CRE RECOMBINASE; MYOSIN HEAVY CHAIN ALPHA; TAMOXIFEN;

ADIPOGENESIS; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; CYTOLOGY; CYTOMEGALOVIRUS; EMBRYO; EMBRYONIC STEM CELL; ENDOPLASMIC RETICULUM; EXCISION; HEART MUSCLE; MOUSE; MUSCLE DEVELOPMENT; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RELIABILITY; UBIQUITINATION; ANIMAL; CELL LINE; CELL LINEAGE; GENE EXPRESSION REGULATION; GENE SILENCING; GENETICS; HEART MUSCLE CELL; METABOLISM; PHYSIOLOGY; PROMOTER REGION;

ANIMALS; CALRETICULIN; CELL DIFFERENTIATION; CELL LINE; CELL LINEAGE; EMBRYONIC STEM CELLS; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; MICE; MYOCYTES, CARDIAC; PROMOTER REGIONS, GENETIC; TAMOXIFEN;

CYTOMEGALOVIRUS;

EID: 60149111555     PISSN: 15473287     EISSN: None     Source Type: Journal    
DOI: 10.1089/scd.2008.0064     Document Type: Article

References (46)

1. Branda CS and SM Dymecki. (2004). Talking about a revolution: The impact of site-specific recombinases on genetic analyses in mice. Dev Cell 6:7-28.
2. Hamilton DL and K Abremski. (1984). Site-specific recombination by the bacteriophage P1 lox-Cre system. Cre-mediated synapsis of two lox sites. J Mol Biol 178:481-486.
3. Lallemand Y, V Luria, R Haffner-Krausz and P Lonai. (1998). Maternally expressed PGK-Cre transgene as a tool for early and uniform activation of the Cre site-specific recombinase. Transgenic Res 7:105-112.
4. Jo D, A Nashabi, C Doxsee, Q Lin, D Unutmaz, J Chen and HE Ruley. (2001). Epigenetic regulation of gene structure and function with a cell-permeable Cre recombinase. Nat Biotechnol 19:929-933.
5. Nolden L, F Edenhofer, S Haupt, P Koch, FT Wunderlich, H Siemen and O Brustle. (2006). Site-specific recombination in human embryonic stem cells induced by cell-permeant Cre recombinase. Nat Methods 3:461-467.
6. Haupt S, F Edenhofer, M Peitz, A Leinhaas and O Brustle. (2007). Stage-specific conditional mutagenesis in mouse embryonic stem cell-derived neural cells and postmitotic neurons by direct delivery of biologically active Cre recombinase. Stem Cells 25:181-188.
7. Akagi K, V Sandig, M Vooijs, V Van d, M Giovannini, M Strauss and A Berns. (1997). Cre-mediated somatic site-specific recombination in mice. Nucleic Acids Res 25:1766-1773.
8. Araki T, M Shibata, R Takano, S Hisahara, S Imamura, Y Fukuuchi, T Saruta, H Okano and Miura M. (2000). Conditional expression of anti-apoptotic protein p35 by Cre-mediated DNA recombination in cardiomyocytes from loxP-p35-transgenic mice. Cell Death Differ 7:485-492.
9. Shibata H, K Toyama, H Shioya, M Ito, M Hirota, S Hasegawa, H Matsumoto, H Takano, T Akiyama, K Toyoshima, R Kanamaru, Y Kanegae, I Saito, Y Nakamura, K Shiba and T Noda. (1997). Rapid colorectal adenoma formation initiated by conditional targeting of the Apc gene. Science 278:120-123.
10. Goverdhana S, M Puntel, W Xiong, JM Zirger, C Barcia, JF Curtin, EB Soffer, S Mondkar, GD King, J Hu, SA Sciascia, M Candolfi, DS Greengold, PR Lowenstein and MG Castro. (2005). Regulatable gene expression systems for gene therapy applications: progress and future challenges. Mol Ther 12:189-211.
11. Vilaboa N and R Voellmy. (2006). Regulatable gene expression systems for gene therapy. Curr Gene Ther 6:421-438.
12. Metzger D, J Clifford, H Chiba and P Chambon. (1995). Conditional site-specific recombination in mammalian cells using a ligand-dependent chimeric Cre recombinase. Proc Natl Acad Sci USA 92:6991-6995.
13. Metzger D and P Chambon. (2001). Site- and time-specific gene targeting in the mouse. Methods 24:71-80.
14. Vooijs M, J Jonkers and A Berns. (2001). A highly efficient ligand-regulated Cre recombinase mouse line shows that LoxP recombination is position dependent. EMBO Rep 2:292-297.
15. Danielian PS, D Muccino, DH Rowitch, SK Michael and AP McMahon. (1998). Modification of gene activity in mouse embryos in utero by a tamoxifen-inducible form of Cre recombinase. Curr Biol 8:1323-1326.
16. Sohal DS, M Nghiem, MA Crackower, SA Witt, TR Kimball, KM Tymitz, JM Penninger and JD Molkentin. (2001). Temporally regulated and tissue-specific gene manipulations in the adult and embryonic heart using a tamoxifen-inducible Cre protein. Circ Res 89:20-25.
17. Guo C, W Yang and CG Lobe. (2002). A Cre recombinase transgene with mosaic, widespread tamoxifen-inducible action. Genesis 32:8-18.
18. Hayashi S and AP McMahon. (2002). Efficient recombination in diverse tissues by a tamoxifen-inducible form of Cre: a tool for temporally regulated gene activation/inactivation in the mouse. Dev Biol 244:305-318.
19. Schnutgen F, AF Stewart, H von Melchner and K Anastassiadis. (2006). Engineering embryonic stem cells with recombinase systems. Methods Enzymol 420:100-136.
20. Mesaeli N, K Nakamura, E Zvaritch, P Dickie, E Dziak, KH Krause, M Opas, DH MacLennan and M Michalak. (1999). Calreticulin is essential for cardiac development. J Cell Biol 144:857-868.
21. Nakamura K, A Zuppini, S Arnaudeau, J Lynch, I Ahsan, R Krause, S Papp, H De Smedt, JB Parys, W Muller-Esterl, DP Lew, KH Krause, N Demaurex, M Opas and M Michalak. (2001). Functional specialization of calreticulin domains. J Cell Biol 154:961-972.
22. Imai T, M Jiang, P Chambon and D Metzger. (2001). Impaired adipogenesis and lipolysis in the mouse upon selective ablation of the retinoid X receptor alpha mediated by a tamoxifen-inducible chimeric Cre recombinase (Cre-E23RT2) in adipocytes. Proc Natl Acad Sci USA 98:224-228.
23. Minamino T, V Gaussin, FJ DeMayo and MD Schneider. (2001). Inducible gene targeting in postnatal myocardium by cardiacspecific expression of a hormone-activated Cre fusion protein. Circ Res 88:587-592.
24. Shai SY, AE Harpf, CJ Babbitt, MC Jordan, MC Fishbein, J Chen, M Omura, TA Leil, KD Becker, M Jiang, DJ Smith, SR Cherry, JC Loftus and RS Ross. (2002). Cardiac myocyte-specific excision of the beta1 integrin gene results in myocardial fibrosis and cardiac failure. Circ Res 90:458-464.
25. Iwatate M, Y Gu, T Dieterle, Y Iwanaga, KL Peterson, M Hoshijima, KR Chien and J Ross. (2003). In vivo high-efficiency transcoronary gene delivery and Cre-LoxP gene switching in the adult mouse heart. Gene Ther 10:1814-1820.
26. Arango NA, PP Szotek, TF Manganaro, E Oliva, PK Donahoe and J Teixeira. (2005). Conditional deletion of beta-catenin in the mesenchyme of the developing mouse uterus results in a switch to adipogenesis in the myometrium. Dev Biol 288:276-283.
27. Vong LH, MJ Ragusa and JJ Schwarz. (2005). Generation of conditional Mef2cloxP/loxP mice for temporal- and tissue-specific analyses. Genesis 43:43-48.
28. Buerger A, O Rozhitskaya, MC Sherwood, AL Dorfman, E Bisping, ED Abel, WT Pu, S Izumo and PY Jay. (2006). Dilated cardiomyopathy resulting from high-level myocardial expression of Cre-recombinase. J Card Fail 12:392-398.
29. Kretz M, D Eckardt, O Kruger, JS Kim, J Maurer, M Theis, HV van Rijen, H Schorle and K Willecke. (2006). Normal embryonic development and cardiac morphogenesis in mice with Wnt1-Cre-mediated deletion of connexin43. Genesis 44:269-276.
30. Zemljic-Harpf AE, JC Miller, SA Henderson, AT Wright, AM Manso, L Elsherif, ND Dalton, AK Thor, GA Perkins, AD McCulloch and RS Ross. (2007). Cardiac-myocyte-specific excision of the vinculin gene disrupts cellular junctions, causing sudden death or dilated cardiomyopathy. Mol Cell Biol 27:7522-7537.
31. Michalak M, EF Corbett, N Mesaeli, K Nakamura and M Opas. (1999). Calreticulin: one protein, one gene and many functions. Biochem J 344:281-292.
32. Bedard K, E Szabo, M Michalak and M Opas. (2005). Cellular functions of endoplasmic reticulum chaperones calreticulin, calnexin, and ERp57. Int Rev Cytol 245:91-121.
33. Szabo E, S Papp and M Opas. (2006). Calreticulin and cellular adhesion/migration-specific signalling pathways. J Appl Biomed 4:45-52.
34. Rauch F, J Prud'homme, A Arabian, S Dedhar and R St Arnaud. (2000). Heart, brain, and body wall defects in mice lacking calreticulin. Exp Cell Res 256:105-111.
35. Bae EJ and SG Kim. (2005). Enhanced CCAAT/enhancer- binding protein beta-liver-enriched inhibitory protein production by Oltipraz, which accompanies CUG repeat-binding protein-1 (CUGBP1) RNA-binding protein activation, leads to inhibition of preadipocyte differentiation. Mol Pharmacol 68:660-669.
36. Szabo E, Y Qiu, S Baksh, M Michalak and M Opas. (2008). Calreticulin inhibits commitment to adipocyte differentiation. J Cell Biol 182:103-116.
37. Littlewood TD, DC Hancock, PS Danielian, MG Parker and GI Evan. (1995). A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins. Nucleic Acids Res 23:1686-1690.
38. Zhang Y, C Riesterer, AM Ayrall, F Sablitzky, TD Littlewood and M Reth. (1996). Inducible site-directed recombination in mouse embryonic stem cells. Nucleic Acids Res 24:543-548.
39. Arakawa H. (2006). Excision of floxed-DNA sequences by transient induction of Mer-Cre-Mer. Subcell Biochem 40:347-349.
40. Schmidt-Supprian M and K Rajewsky. (2007). Vagaries of conditional gene targeting. Nat Immunol 8:665-668.
41. Schmidt EE, DS Taylor, JR Prigge, S Barnett and MR Capecchi. (2000). Illegitimate Cre-dependent chromosome rearrangements in transgenic mouse spermatids. Proc Natl Acad Sci USA 97:13702-13707.
42. Loonstra A, M Vooijs, HB Beverloo, BA Allak, E van Drunen, R Kanaar, A Berns and Jonkers J. (2001). Growth inhibition and DNA damage induced by Cre recombinase in mammalian cells. Proc Natl Acad Sci USA 98:9209-9214.
43. Hameyer D, A Loonstra, L Eshkind, S Schmitt, C Antunes, A Groen, E Bindels, J Jonkers, P Krimpenfort, R Meuwissen, L Rijswijk, A Bex, A Berns and E Bockamp. (2007). Toxicity of ligand-dependent Cre recombinases and generation of a conditional Cre deleter mouse allowing mosaic recombination in peripheral tissues. Physiol Genomics 31:32-41.
44. Naiche LA and VE Papaioannou. (2007). Cre activity causes widespread apoptosis and lethal anemia during embryonic development. Genesis 45:768-775.
45. Baba Y, M Nakano, Y Yamada, I Saito and Y Kanegae. (2005). Practical range of effective dose for Cre recombinase- expressing recombinant adenovirus without cell toxicity in mammalian cells. Microbiol Immunol 49:559-570.
46. Denning GM, KG Leidal, VA Holst, SS Iyer, DW Pearson, JR Clark, WM Nauseef and RA Clark. (1997). Calreticulin biosynthesis and processing in human myeloid cells: demonstration of signal peptide cleavage and N-glycosylation. Blood 90:372-381.